To
investigate the effects of 3-aminopropyltriethoxysilane (APTES)-
or (3-mercaptopropyl)trimethoxysilane (MPTS)-conditioned nanozirconia
fillers on the mechanical properties of Bis-GMA-based resin composites.
The conditioned fillers were characterized by Fourier transform infrared
(FTIR) spectroscopy, X-ray photoelectron spectroscopy (XPS), and thermodynamic
calculations. They were then used to prepare Bis-GMA-based resin composites,
whose flexural strength and elastic modulus were evaluated. The Cell
Counting Kit-8 (CCK-8) assessed the composites’ cytotoxicity.
The FTIR spectra of the conditioned fillers showed new absorption
bands at 1569 and 1100 cm
–1
, indicating successful
grafting of APTES or MPTS onto nanozirconia. XPS confirmed the Zr–O–Si
bonds in the APTES- or MPTS-conditioned fillers at contents of 2.02
and 6.98%, respectively. Thermodynamic calculations reaffirmed the
chemical binding between the two silanes and nanozirconia fillers.
Composites containing the conditioned nanozirconia fillers had significantly
greater flexural strengths (APTES, 121.02 ± 8.31 MPa; MPTS, 132.80
± 15.80 MPa; control, 94.84 ± 9.28 MPa) and elastic moduli
(8.76 ± 0.52, 9.24 ± 0.60, and 7.44 ± 0.83 GPa, respectively)
than a control with untreated fillers. The cytotoxicity assay identified
no significant cytotoxicity by composites containing the conditioned
fillers. Silanes were previously considered to be unable to chemically
condition zirconia to bond with resin. Inclusion of APTES- or MPTS-conditioned
nanozirconia fillers can improve the mechanical properties of Bis-GMA-based
resin composites without obvious cytotoxicity in this study.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.